Rapid weight loss using a very low-calorie diet (VLCD) for 2 to 3 months followed by weight maintenance has been shown to lead to the restoration of normal glucose and insulin metabolism in people recently diagnosed with type 2 diabetes. We explored the barriers and facilitators of adhering to a VLCD for remission in an Afro-Caribbean population. Twenty-five participants completed an eight-week VLCD followed by a six-month structured weight maintenance phase. Semi-structured interviews and focus groups were thematically analysed. Cravings for ‘usual foods’ consumed by friends and family, stigma of diabetes and resulting lack of disclosure and the participants’ busy schedules were noted as predominant challenges throughout the study. In turn, social support and the participants’ internal drive were considered as key facilitators for success. VLCD is a feasible approach for type 2 diabetes remission. Self-motivation and supportive environments are however crucial in meeting and maintaining the weight loss goals.

The authors have declared no competing interest.

NA

This study was made possible through the financial assistance offered by Virgin Unite. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Not Applicable

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval was obtained from the University of the West Indies Institutional Review Board and the Ministry of Health of the Government of Barbados.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Not Applicable

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Not Applicable

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Not Applicable

The data that support the findings of this study are available on request from the corresponding author (NU).